Quarterly report pursuant to Section 13 or 15(d)

Stock Compensation

v3.10.0.1
Stock Compensation
9 Months Ended
Sep. 30, 2018
Stock Compensation [Abstract]  
STOCK COMPENSATION

NOTE 11 – STOCK COMPENSATION

Equity Incentive Plan

In November 2016, the Company increased the number of shares available for issuance under its 2012 Equity Incentive Plan (as amended, the “Plan”) from 550,000 to 850,000, which was approved by the Company’s shareholders in December 2016. The Plan provides for grants of stock options, stock appreciation rights, restricted stock, other stock-based awards and other cash-based awards. As of September 30, 2018, the remaining shares of common stock available for future issuances of awards was 231,260. The Company granted an aggregate of 30,000 options to purchase restricted common stock to certain directors prior to the adoption of the Plan. Stock options generally vest and become exercisable with respect to 100% of the common stock subject to such stock option on the third (3rd) anniversary of the date of grant. Any unvested portion of a stock option shall expire upon termination of employment or service of the participant granted the stock option, and the vested portion shall remain exercisable in accordance with the provisions of the Plan.

 

Stock Options

 

The following table summarizes stock option activity for the nine months ended September 30, 2018:

                Weighted  
          Weighted     Average  
    Shares     Average     Remaining  
    Under     Exercise     Contractual  
    Options     Price     Term (Years)  
Balance at December 31, 2017     561,740     $ 7.32       5.61  
Options granted     57,000       4.00       9.50  
Options canceled     (10,000 )     4.00       -  
Balance at September 30, 2018     608,740     $ 6.76       5.65  

 

At September 30, 2018 and December 31, 2017, the exercisable options had no intrinsic value.

 

As of September 30, 2018, 253,310 options have vested and 355,430 options remain unvested. The vesting terms range from zero to 9.50 years and the vested options have a weighted average remaining term of 5.65 years and a weighted average exercise price of $6.76 per share.

 

The weighted average grant date fair value of the 57,000 stock options granted during the nine months ended September 30, 2018 was $0.32. The following table summarizes the assumptions used to value stock using a Black-Scholes model:

Expected annualized volatility:     50.00 %
Annual risk-free interest rate:     2.38 %
Expected time to maturity:     7 years  
Exercise Price   $ 4.00  

 

The risk-free rate is based on the U.S. Treasury rate for a note with a similar term in effect at the time of the grant. The expected annualized volatility is based on the volatility of the Company’s historical stock prices.

 

Restricted Stock

 

The following table summarizes unvested restricted stock awards activity for the nine months ended September 30, 2018:

          Weighted  
          Average  
          Grant Date  
    Shares     Share Price  
Restricted stock awards unvested at December 31, 2017     1,250     $ 2.74  
Granted     55,147       1.36  
Vested     (56,397 )     1.39  
Restricted stock awards unvested at September 30, 2018     -          

 

Stock-Based Compensation:

 

Stock-based compensation consists of expenses related to the issuance of stock options and restricted stock. Stock-based compensation expenses were $30 and $39 for the three months ended September 30, 2018 and 2017, respectively, and $195 and $121 for the nine months ended September 30, 2018 and 2017, respectively.

 

The aggregate unrecognized compensation expense of stock options and restricted stock at September 30, 2018 was $73, which will be recognized through January 2021.